Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Neurogastrx Inc.

Headquarters: Boston, MA, United States of America
Year Founded: 2012
Status: Private

BioCentury | Oct 22, 2024
Product Development

Otsuka to take advantage of newly charted accelerated pathway for IgA nephropathy

BioCentury’s Clinical Report analyzes a pair of GLP-1 agonist updates, plus data from Amylyx’s ALS therapy in a new indication, and more
BioCentury | Aug 9, 2023
Management Tracks

Baum returns as Mirati CEO as Meek departs

Plus: Voyager hires Shafer as CBO and updates from X4 and Mekonos
BioCentury | Aug 26, 2021
Finance

Neurogastrx: $60M crossover round to advance de-risked GI assets

Emerging Company Profile: Funding, assist from Vivo to land Phase III-ready Daewoong asset readies biotech to build on its CEO’s Ironwood roots
BioCentury | Jan 5, 2018
Financial News

Neurogastrx raises $45M series A

BioCentury | Jan 4, 2018
Financial News

GI company Neurogastrx in $45M series A

Items per page:
1 - 6 of 6